𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression

✍ Scribed by Michael Bauer; Puvan Tharmanathan; Hans-Peter Volz; Hans-Juergen Moeller; Nick Freemantle

Publisher
Springer-Verlag
Year
2009
Tongue
English
Weight
350 KB
Volume
259
Category
Article
ISSN
1433-8491

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Neuroendocrine and anthropometric measur
Neuroendocrine and anthropometric measures in major depression: the effect of antidepressant treatment
✍ Arun Ravindran; Robert Bialik; Pavel Hrdina; Zul Merali; Hymie Anisman; Yvon Lap πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 133 KB πŸ‘ 2 views

It has been suggested that weight change might be associated with certain neuroendocrine abnormalities often observed in patients suering from a depressive illness. This preliminary study examined whether objective measures of weight change were associated with dexamethasone suppression test (DST) r

The treatment of depression with differe
The treatment of depression with different formulations of venlafaxine: a comparative analysis
✍ James S. Olver; Graham D. Burrows; Trevor R. Norman πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 80 KB πŸ‘ 1 views

## Abstract Venlafaxine is the first of a group of antidepressants that show dual reuptake inhibition of serotonin and noradrenaline (SNRIs). Originally marketed in an immediate release (IR) formulation a microencapsulated, extended release (XR) formulation is now available. Significant differences

Venlafaxine in the treatment of depressi
Venlafaxine in the treatment of depressive and vasomotor symptoms in women with perimenopausal depression
✍ Charlotte O. Ladd; D. Jeffrey Newport; Kimberly A. Ragan; Ada Loughhead; Zachary πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 74 KB πŸ‘ 1 views

Perimenopause is often marked by vasomotor symptoms and dysphoria. Antidepressant studies have demonstrated decreased frequency and severity of hot flashes in breast cancer survivors and menopausal women. We hypothesized that venlafaxine would relieve both depressive and vasomotor symptoms in depres

A double blind, placebo-controlled pilot
A double blind, placebo-controlled pilot study of galantamine augmentation of antidepressant treatment in older adults with major depression
✍ Paul E. Holtzheimer III; Thomas W. Meeks; Mary E. Kelley; Mustafa Mufti; Raymond πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 105 KB πŸ‘ 2 views

## Abstract ## Objective Depression in older adults is often associated with cognitive abnormalities and may predict later development of a primary cognitive disorder. This double‐blind, randomized, placebo‐controlled pilot study was designed to assess the safety and efficacy of galantamine augmen